|
| Code | Diagnosis | Comment | Score |
| anonymous | Angioimmunoblastic T cell lymphoma (100%) | Immunostains for B and T cell markers and follicular dendritic cell marker to confirm diagnosis. Lymphoma cells will be positive for T marker. Meshworks of follicular dendritic cells will be shown. | 100 |
| anonymous | Angioimmunoblastic T-cell lymphoma | nil | 100 |
| anonymous | Angioimmunoblastic T-cell lymphoma (100%) | Confirm diagnosis by immunostains (CD2,3,4,5,7,8). Additional studies, i.e. ISH for EBER and PCR for T-cell receptor gene rearrangement may be performed. | 100 |
| anonymous | Angioimmunoblastic T-cell lymphoma | Confirm by immunostaining: lymphoma cells positive for T cell markers; follicular dendritic cells abundant (CD21+). | 100 |
| anonymous | Angioimmunoblastic T-cell lymphoma 100%. | nil | 100 |
| anonymous | Angioimmunoblastic T-cell lymphoma. (100%) | Confirm by doing immunostains of lymphoma panel and EBER. | 100 |
| anonymous | AILD-like Anaplastic large cell lymphoma 100% | To correlate with results of immunostains: T-cell and CD30 and ALK1 | 80 |
| anonymous | Malignant lymphoma, favour angioimmunoblastic T-cell lymphoma | Perform immunohistochemical panel : CD3, CD20. Lesion cells expected to be CD3+. CD21/CD35 will show an expanded follicular dendritic cell meshwork. | 100 |
| anonymous | Angioimmunoblastic T cell lymphoma | nil | 100 |
| anonymous | ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA; confirm with immunostaining for CD3, CD4, CD8, CD20, CD21 (100%) | nil | 100 |
| anonymous | Angioimmunoblastic lymphadenopathy/lymphoma 100% | TCR and Ig rearrangement studies for clonality and CD10 immuno to support diagnosis of lymphoma | 100 |
| anonymous | Angioimmunoblastic T-cell lymphoma | To be confirmed by immunohistochemistry: CD3+, L26-; might perform CD21 and CD35 to highlight follicular dendritic cell network. | 100 |
| anonymous | Angioimmunoblastic T cell lymphoma | nil | 100 |
| anonymous | Follicular dendritic cell sarcoma, interdigitating dendritic cell sarcoma, angioimmunoblastic T-cell lymphoma. Do S100, CD21 and CD35, CD3 and CD20. Probability: 100% | nil | 100 |
| anonymous | Angioimmunoblastic T cell lymphoma 100% | Perform T and B cell markers and CD21 to confirm T cell proliferation and follicular dendritic cell population | 100 |
| anonymous | Angioimmunoblastic T cell lymphoma (90%) Follicular dendritic cell sarcoma (10%) | Immunohistochemical staining for CD3, CD21, CD35 to highlight the atypical cells. | 100 |